1c:{"metadata":[["$","title","0",{"children":"NIH VideoCast - Novel Omega-3 Mediators & Mechanisms in the Resolution of Inflammation: What Can they Tell us About Preventative and Therapeutic Approaches?"}],["$","meta","1",{"name":"description","content":"Stars in Nutrition and Cancer\n

\nObjectives
\nDefine the functional differences between anti-inflammation versus pro-resolution and the cell types involved; \n

Define the anti-inflammatory and pro-resolving lipid mediators; \nReview the biosynthesis and omega-3 precursors (EPA and DHA) of the resolvins, protectins and maresins (E-series vs. D-series resolvins) and their actions; \n

Define the resolution indices: what enhances resolution and the drugs that are resolution toxic; and \n

What are the key cellular targets of the resolvins and mechanism(s) (e.g. receptors, miR, etc.) that define resolving autacoids in animal inflammatory diseases. \n\n

For more information go to http://prevention.cancer.gov/news-events/events/20120313"}],["$","meta","2",{"name":"publisher","content":"National Institutes of Health"}],["$","meta","3",{"property":"og:title","content":"NIH VideoCast - Novel Omega-3 Mediators & Mechanisms in the Resolution of Inflammation: What Can they Tell us About Preventative and Therapeutic Approaches?"}],["$","meta","4",{"property":"og:description","content":"Stars in Nutrition and Cancer\n

\nObjectives
\nDefine the functional differences between anti-inflammation versus pro-resolution and the cell types involved; \n

Define the anti-inflammatory and pro-resolving lipid mediators; \nReview the biosynthesis and omega-3 precursors (EPA and DHA) of the resolvins, protectins and maresins (E-series vs. D-series resolvins) and their actions; \n

Define the resolution indices: what enhances resolution and the drugs that are resolution toxic; and \n

What are the key cellular targets of the resolvins and mechanism(s) (e.g. receptors, miR, etc.) that define resolving autacoids in animal inflammatory diseases. \n\n

For more information go to http://prevention.cancer.gov/news-events/events/20120313"}],["$","meta","5",{"property":"og:url","content":"https://uat.d1rkikwu4q8tg.amplifyapp.com/watch/a362eb1c-d5db-11f0-9cf9-12c45c580ad9"}],["$","meta","6",{"property":"og:site_name","content":"NIH VideoCast"}],["$","meta","7",{"property":"og:image","content":"https://nihcit.rev.vbrick.com/api/v2/media/videos/thumbnails/33d69d2b-0f56-47f3-b01e-e6fae2ee7e41.jpg"}],["$","meta","8",{"property":"og:type","content":"website"}],["$","meta","9",{"name":"twitter:card","content":"summary_large_image"}],["$","meta","10",{"name":"twitter:title","content":"NIH VideoCast - Novel Omega-3 Mediators & Mechanisms in the Resolution of Inflammation: What Can they Tell us About Preventative and Therapeutic Approaches?"}],["$","meta","11",{"name":"twitter:description","content":"Stars in Nutrition and Cancer\n

\nObjectives
\nDefine the functional differences between anti-inflammation versus pro-resolution and the cell types involved; \n

Define the anti-inflammatory and pro-resolving lipid mediators; \nReview the biosynthesis and omega-3 precursors (EPA and DHA) of the resolvins, protectins and maresins (E-series vs. D-series resolvins) and their actions; \n

Define the resolution indices: what enhances resolution and the drugs that are resolution toxic; and \n

What are the key cellular targets of the resolvins and mechanism(s) (e.g. receptors, miR, etc.) that define resolving autacoids in animal inflammatory diseases. \n\n

For more information go to http://prevention.cancer.gov/news-events/events/20120313"}],"$L22","$L23","$L24"],"error":null,"digest":"$undefined"}